Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @cancercommons
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cancercommons
-
Cancer Commons proslijedio/la je Tweet
"For every patient who is diagnosed w/ stage IV
#colorectalcancer (mCRC), complete molecular profiling of their tumor is highly recommended. It is important for pts to know their microsatellite status, RAS (KRAS & NRAS) & BRAF mutations, & HER2 amplification status at a minimum."https://twitter.com/cancercommons/status/1225091993501519872 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#CuriousDrGeorge asks Kalpana Kannan, PhD, about new targeted and immunotherapy options that have come on the scene for people w/ advanced#colorectalcancer: https://www.cancercommons.org/curious-dr-george/using-molecular-testing-to-guide-treatment-for-advanced-colorectal-cancer/ …#CRCSM#ColonCancerpic.twitter.com/BYXvo7UIpU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our expert network is ready to help you answer your questions about cancer treatment, clinical trials, and more. Get one-on-one support today: https://www.cancercommons.org/patients/
#bcsm#btsm#lcsm#amsm#glioblastoma#PancSMpic.twitter.com/ND7vb6VUmk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
After an advanced cancer diagnosis, what questions should you ask your doctor? Our experts weigh in: https://www.cancercommons.org/cancer-insights/what-questions-should-i-ask-my-doctor/ …
#amsm#btsm#PancSm#lcsmpic.twitter.com/tzupBL03an
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#tbt What does a retired globetrotter do when diagnosed with#breastcancer abroad?@EllieMae411 generously shares her story: https://www.cancercommons.org/type-of-cancer/type-breast-cancer/an-early-retired-globetrotter-navigates-breast-cancer-treatment-abroad/ …#bcsmpic.twitter.com/xabrsrkJeI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re thrilled to have shared promising initial findings from our real-world data registry on a novel treatment for
#PancreaticCancer earlier this month at#aacrrwd20. Thank you to collaborators at xCures &@huntsmancancer. More from@LolaRahib: https://www.cancercommons.org/cancer-insights/using-real-world-evidence-to-show-initial-results-of-a-drug-combination-in-pancreatic-cancer-patients/ …#pancsmpic.twitter.com/FRsKPmTH13
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to everyone who attended and participated in our dedicated Patient Track at
#PMWC20 last week! We believe in keeping patients' needs at the center of conversations about oncology, and we're thrilled to have heard so many valuable perspectives.#precisionmedicinepic.twitter.com/X42kmSaU0Q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you or a loved one dealing with a new cancer diagnosis? Cancer Commons can help. Sign up for our free services at https://www.cancercommons.org/patients/ pic.twitter.com/1qU5souQ65
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As we embrace 2020, we reflect on the previous year w/ deep gratitude for our generous donors. Their philanthropic support made 2019 a year of great progress for us & the patients we serve. To everyone who gave what they could, thank you. We couldn’t have done it without you.pic.twitter.com/v8lRlOPYFn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Commons proslijedio/la je Tweet
Today,
@SEngineMedicine’s@cgrandori joins@CancerCommons@Martytenenbaum & a panel of industry leaders at#PMWC20 to explore how functional precision medicine impacts#cancer patients, particularly ovarian, & how new tech & partnerships will shape clinical oncology's future.pic.twitter.com/PHyzgqzonZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Commons proslijedio/la je Tweet
We are all patients. Some r
#cancer patients.@cancercommons cares.#PMWC20 focuses a patient track 1/24/2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Commons proslijedio/la je Tweet
Precision oncology works well for SOME cancer patients
@cancercommons is explaining the best ways#PMWC20 Hope; not Hype with real#science can succeedHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we’re thrilled to be co-hosting a dedicated Patient Track at
#PMWC20, w/ great speakers lined up to share their perspectives on putting patients first. More info: https://www.pmwcintl.com/session/patient-track_2020sv/ … Hope to see you there!#precisionmedicinepic.twitter.com/HNwt3e4hpt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#tbt "In a perfect world, I see Cancer Commons’ services as an integral part of a patient’s treatment plan." Read Marilou's#cervicalcancer story: https://www.cancercommons.org/super-patients/marilou-shares-her-experience-as-a-young-woman-with-advanced-cervical-cancer/ …#GynCSMpic.twitter.com/PBJwzhtdjI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Commons proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Cancer Commons proslijedio/la je Tweet
In 1 1/2 weeks!
@googlecloud's Shweta Singh Maniar will chair "AI/ML-Driven Clinical Trial Design and Patient Selection"#PMWC20 Speakers >@marcfiume@DNAstack > M. Ali@Boehringer_bio > A. Schneider@MolecularHealth >@EmmaShtivelman@cancercommons https://www.pmwcintl.com/session/ai-ml-driven-clinical-trial-design-and-patient-selection_2020sv/ …pic.twitter.com/DGQJwPzowP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our expert network is ready to help you answer your questions about cancer treatment, clinical trials, and more. Get support today: https://www.cancercommons.org/patients/
#bcsm#btsm#lcsm#amsm#glioblastoma#PancSMpic.twitter.com/s9H5HFvBgh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Renal Cell Cancer Treatment: The Old, the Almost Old, and the New https://www.cancercommons.org/cancer-insights/renal-cell-cancer-treatment-the-old-the-almost-old-and-the-new/ …
#amsm#kidneycancerpic.twitter.com/9WA3sdTdtd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“Though the study includes a small number of patients...this regimen could potentially be an option for this group of patients who don’t have many more options.” Excited to share initial results from our registry on a novel
#PancreaticCancer tx: https://www.cancercommons.org/cancer-insights/using-real-world-evidence-to-show-initial-results-of-a-drug-combination-in-pancreatic-cancer-patients/ …#PancSMpic.twitter.com/xVD7V3DIz2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Coming up soon! We’ve co-organized a dedicated Patient Track at
#PMWC20, w/ great speakers lined up to share their perspectives on putting patients first. Patients can register at a steep discount. More info: https://www.cancercommons.org/press-and-events/patients-and-caregivers-invited-to-attend-special-track-at-pmwc-2020/ … Hope to see you there.#precisionmedicinepic.twitter.com/SyRFlEZUOM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.